A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report.

Documenti analoghi

• A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma
  di: Burton, C, et al.
  Pubblicazione: (2006)
• Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy.
  di: Vaughan Hudson, B., et al.
  Pubblicazione: (1994)
• Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation.
  di: Vaughan Hudson, B, et al.
  Pubblicazione: (1987)
• Primary gastrointestinal non-Hodgkin's lymphoma: a review of 175 British National Lymphoma Investigation cases.
  di: Morton, J. E., et al.
  Pubblicazione: (1993)
• High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML
  di: Harrison, C N, et al.
  Pubblicazione: (1999)